BeStock  
Markets › Compare › TSHA vs STOK

TSHA vs STOK

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TSHA · Taysha Gene Therapies$4.49 ▼ 3.02%
STOK · Stoke Therapeutics$25.32 ▼ 1.17%

Head to head

MetricTSHASTOK
Price$4.49$25.32
Change today▼ 3.02%▼ 1.17%
Market cap$1.46B$1.63B
Return, 3 months–-23.3%
Return, year to date–-20.2%
Return, 1 year–-5.6%
P/E (TTM)-11.0-7.6
P/B3.84.7
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)–-32.5%
Net profit growth (YoY)–-162.4%
Gross margin––
Operating margin–-809.7%
Net margin–-753.6%
Return on equity–-61.1%
Analyst target vs. price–+78.2%
Analyst buy share–100%
RSI (14)–34
30-day volatility–45.2%
Max drawdown, 1 year–-37.2%
Trend read–Strong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • STOK is the largest of the group by market value.
  • TSHA carries the lowest trailing P/E.

Go deeper

Scroll to Top